Calcium creatinine ratio (Spot)
Kidney0 parametersReport in 4HrsAt Home
Fasting Required
Details
Evaluates serum calcium, essential for bones, muscle function, nerve signaling, and cardiac health.
₹449₹662
32% OFF
FREE:AI Insights
Calcium Creatinine Ratio (Spot) - Comprehensive Medical Test Guide
- Why is it done?
- Test measures the ratio of calcium to creatinine in a single spot urine sample to assess calcium excretion normalized by kidney function
- Screening for hypercalciuria (elevated urinary calcium) which may indicate kidney stone formation risk, bone metabolism disorders, or primary hyperparathyroidism
- Evaluation of hypocalciuria (low urinary calcium) suggesting absorption disorders or vitamin D deficiency
- Investigating recurrent kidney stones or nephrolithiasis risk stratification
- Monitoring patients with suspected or confirmed primary hyperparathyroidism
- Assessing bone metabolism and calcium homeostasis in metabolic bone disease
- Evaluating chronic kidney disease progression and mineral metabolism changes
- Performed as a single spot urine collection at any time of day, commonly used in initial screening before more extensive 24-hour urine studies
- Normal Range
- Normal Range: 0.0 to 0.30 mg/mg creatinine (or mmol/mmol creatinine)
- Alternative Units: 0.0 to 0.20 mg/mg creatinine (stricter definition for some labs)
- Interpretation:
- Normal (Low): Ratio ≤0.20 mg/mg indicates adequate calcium excretion with low stone forming risk
- Borderline: Ratio 0.20-0.30 mg/mg may suggest mild elevation warranting clinical correlation
- Elevated (High): Ratio >0.30 mg/mg indicates hypercalciuria, increased kidney stone risk, and requires further investigation
- Units of Measurement: mg/mg creatinine (most common) mmol/mmol creatinine (SI units)
- The ratio normalizes calcium excretion to glomerular filtration rate, making it independent of urine volume and allowing for random spot collection rather than timed 24-hour urine
- Interpretation
- Elevated Ratio (>0.30 mg/mg) - Indicates Hypercalciuria:
- Significantly increased risk for calcium-based kidney stone formation (calcium oxalate or calcium phosphate stones)
- Suggests primary hyperparathyroidism with PTH-mediated increase in renal calcium reabsorption inhibition
- May indicate sarcoidosis or other granulomatous disease with calcitriol overproduction
- Can reflect vitamin D intoxication or excessive supplementation
- May represent idiopathic hypercalciuria (familial or sporadic form)
- Low or Normal Ratio (≤0.20 mg/mg) - Indicates Eucalciuria or Hypocalciuria:
- Normal calcium excretion with low risk for calcium-based kidney stone formation
- If persistently low, may suggest vitamin D deficiency or malabsorption syndrome
- May indicate hypoparathyroidism if accompanied by low serum calcium
- Factors Affecting Results:
- Dietary calcium intake - high calcium diet increases urinary calcium excretion
- Sodium intake - high sodium increases urinary calcium via natriuresis
- Protein intake - excessive dietary protein increases urinary calcium
- Medications - thiazide diuretics decrease urinary calcium; loop diuretics increase it
- Time of day - urinary calcium tends to be higher in afternoon/evening samples
- Physical activity level - immobilization increases urinary calcium excretion
- Renal function - creatinine normalization requires stable kidney function; unreliable in severe renal disease
- Associated Organs
- Primary Organ Systems:
- Kidneys - primary filtration and reabsorption of calcium; site of nephrolithiasis (kidney stone formation)
- Parathyroid glands - PTH regulation of calcium reabsorption in proximal and distal tubules
- Bones - source of calcium mobilization; target organ for calcium metabolism disorders
- Gastrointestinal tract - site of dietary calcium absorption regulated by vitamin D
- Diseases Associated with Abnormal Results:
- Elevated Ratio Associated Conditions:
- Primary hyperparathyroidism - most common pathological cause of hypercalciuria
- Nephrolithiasis/Kidney stones - recurrent or multiple calcium-based stones
- Sarcoidosis - with elevated calcitriol and hypercalciuria
- Hyperthyroidism - increased metabolic rate and bone turnover
- Multiple myeloma - bone destruction with hypercalcemia and hypercalciuria
- Vitamin D intoxication or excessive supplementation
- Idiopathic hypercalciuria - genetic or acquired form without hypercalcemia
- Paget's disease of bone - with increased bone turnover
- Hyperthermia or prolonged immobilization - causing bone resorption
- Low Ratio Associated Conditions:
- Vitamin D deficiency - impaired intestinal calcium absorption
- Malabsorption syndrome - celiac disease, inflammatory bowel disease
- Hypoparathyroidism - reduced PTH-mediated renal calcium reabsorption
- Renal tubular acidosis - impaired calcium reabsorption
- Potential Complications of Abnormal Results:
- Recurrent nephrolithiasis - chronic kidney stone disease with potential renal damage
- Chronic kidney disease progression - from repeated stone passage and obstruction
- Nephrocalcinosis - calcium deposition in renal tissue causing functional impairment
- Bone loss and osteoporosis - from chronic hypercalciuria and associated bone resorption
- Acute renal failure - from uric acid obstruction or severe hypercalcemia
- Follow-up Tests
- If Elevated Calcium-Creatinine Ratio:
- Serum calcium and ionized calcium - to assess hypercalcemia
- Serum PTH (parathyroid hormone) - evaluate for primary hyperparathyroidism
- Serum phosphate and vitamin D (25-OH vitamin D and calcitriol) - assess vitamin D metabolism
- 24-hour urine calcium - more comprehensive assessment of calcium excretion if spot ratio elevated
- 24-hour urine phosphate and uric acid - identify other stone-forming substances
- Urine pH and citrate - evaluate urine factors promoting stone formation
- Serum creatinine and eGFR - assess kidney function baseline
- Renal ultrasound or CT scan - detect existing stones or nephrocalcinosis
- ACE level and serum calcium - if sarcoidosis suspected
- If Low Calcium-Creatinine Ratio:
- Serum calcium and albumin - assess for true hypocalcemia
- Serum PTH - evaluate parathyroid function
- Vitamin D 25-OH - assess vitamin D deficiency status
- Serum phosphate - assess hypophosphatemia or secondary hyperparathyroidism
- Tissue transglutaminase (tTG) IgA - screen for celiac disease if malabsorption suspected
- Monitoring Frequency:
- Recurrent kidney stone formers: Annual or biannual spot urine calcium creatinine ratio monitoring
- Post-treatment evaluation: 4-6 weeks after initiating stone prevention therapy
- Hyperparathyroidism management: Periodically during medical optimization or post-surgery surveillance
- Chronic kidney disease patients: Every 3-6 months to monitor mineral metabolism changes
- Related Complementary Tests:
- Urine oxalate/creatinine ratio - identifies second major stone-forming substance
- Urine citrate/creatinine ratio - citrate inhibits stone formation
- Urine magnesium/creatinine ratio - magnesium inhibits calcium stone formation
- Fasting Required?
- Fasting Requirement: NO - Fasting is not required for a spot urine calcium creatinine ratio
- Sample Collection:
- Single random urine specimen collection - can be collected at any time of day
- Preferably midstream clean-catch technique for accurate results
- No special container preparation required beyond standard urine collection cup
- Dietary Modifications (Recommended to Standardize Results):
- Maintain normal dietary calcium intake - neither restrict nor supplement unless specifically instructed
- Reduce sodium intake 24 hours prior - high sodium falsely elevates urinary calcium
- Avoid excessive protein intake - high protein diet increases calcium excretion
- Maintain normal hydration status - dehydration concentrates urine and may affect ratio
- Medications to Avoid or Adjust:
- Thiazide diuretics - decrease urinary calcium and should be continued (do not stop)
- Loop diuretics - increase urinary calcium; consult physician before stopping
- Vitamin D supplements - excessive amounts falsely elevate calcium excretion; maintain consistent dose
- Calcium supplements - maintain normal dosing, do not change timing without physician guidance
- NSAIDs - continue as prescribed; may affect both calcium and creatinine measurements
- Patient Preparation Instructions:
- Can eat and drink normally - no dietary restrictions required
- Adequate hydration - drink normal amounts of water and fluids
- Continue all regularly scheduled medications unless instructed otherwise by physician
- Report current medications and supplements to laboratory staff
- Collect specimen in clean, sterile urine cup provided by laboratory
- Label specimen clearly with name, date, and time of collection
- Submit promptly to laboratory - ideally within 1-2 hours of collection
- If delayed transport, refrigerate specimen until laboratory processing
How our test process works!
